Dexamethasone suppresses interleukin-1β-induced human β-defensin 2 mRNA expression: Involvement of p38 MAPK, JNK, MKP-1, and NF-κB transcriptional factor in A549 cells

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 1, 2007, Pages 171-184

  Jang, Byeong Churl ^a   Lim, Ki Jo ^a   Suh, Min Ho ^a   Park, Jong Gu ^a   Suh, Seong Il ^a  

^a Keimyung University   (South Korea)

Author keywords

Defensin; Dexamethasone; IL 1 ; MKP 1; NF B; p38 MAPK

Indexed keywords

BETA DEFENSIN 2; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NF-KAPPA B P65 SUBUNIT; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

BETA-DEFENSINS; CELL CYCLE PROTEINS; CELL LINE; DEXAMETHASONE; GENE EXPRESSION REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER;

EID: 34548587913     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00293.x     Document Type: Article

References (40)

1. Adcock IM Caramori G (2001) Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 79 : 376 384.
2. Auphan N, DiDonato JA, Rosette C, Helmberg A Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 : 286 290.
3. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W Haegeman G (1997) Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA 94 : 13504 13509.
4. De Bosscher K, Vanden Berghe W Haegeman G (2000) Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 109 : 16 22.
5. De Smet K Contreras R (2005) Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27 : 1337 1347.
6. Duits LA, Rademaker M, Ravensbergen B, van Sterkenburg MA, van Strijen E, Hiemstra PS Nibbering PH (2001) Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids. Biochem Biophys Res Commun 280 : 522 525.
7. Engelbrecht Y, de Wet H, Horsch K, Langeveldt CR, Hough FS Hulley PA (2003) Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144 : 412 422.
8. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R Forssmann WG (2001) Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. Faseb J 15 : 1819 1821.
9. Han CW, Choi JH, Kim JM, Kim WY, Lee KY Oh GT (2001) Glucocorticoid- mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha. Rheumatology (Oxford) 40 : 267 273.
10. Harder J, Bartels J, Christophers E Schroder JM (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 : 5707 5713.
11. Huttner KM Bevins CL (1999) Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 45 : 785 794.
12. Isobe T Lillehoj HS (1993) Dexamethasone suppresses T cell-mediated immunity and enhances disease susceptibility to eimeria mivati infection. Vet Immunol Immunopathol 39 : 431 446.
13. Jang BC, Lim KJ, Paik JH et al 2004) Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB. Biochem Biophys Res Commun 320 : 1026 1033.
14. Keyse SM (2000) Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12 : 186 192.
15. Lasa M, Abraham SM, Boucheron C, Saklatvala J Clark AR (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22 : 7802 7811.
16. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM Liu Y (2001) Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol 21 : 8213 8224.
17. Ma W, Gee K, Lim W, Chambers K, Angel JB, Kozlowski M Kumar A (2004) Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors. J Immunol 172 : 318 330.
18. McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L Proske RJ (2003) Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci 44 : 1859 1865.
19. Meyer JE, Harder J, Gorogh T, Weise JB, Schubert S, Janssen D Maune S (2004) Human beta-defensin-2 in oral cancer with opportunistic Candida infection. Anticancer Res 24 : 1025 1030.
20. Mineshiba J, Myokai F, Mineshiba F, Matsuura K, Nishimura F Takashiba S (2005) Transcriptional regulation of beta-defensin-2 by lipopolysaccharide in cultured human cervical carcinoma (HeLa) cells. FEMS Immunol Med Microbiol 45 : 37 44.
21. Misra-Press A, Rim CS, Yao H, Roberson MS Stork PJ (1995) A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J Biol Chem 270 : 14587 14596.
22. Newton R (2000) Molecular mechanisms of glucocorticoid action: what is important? Thorax 55 : 603 613.
23. Newton R, Hart LA, Stevens DA, Bergmann M, Donnelly LE, Adcock IM Barnes PJ (1998) Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells. Eur J Biochem 254 : 81 89.
24. Rozkova D, Horvath R, Bartunkova J Spisek R (2006) Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of toll-like receptors. Clin Immunol 120 : 260 271.
25. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA Baldwin AS Jr. (1995) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15 : 943 953.
26. Shepherd EG, Zhao Q, Welty SE, Hansen TN, Smith CV Liu Y (2004) The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J Biol Chem 279 : 54023 54031.
27. Slack DN, Seternes OM, Gabrielsen M Keyse SM (2001) Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J Biol Chem 276 : 16491 16500.
28. Starner TD, Agerberth B, Gudmundsson GH McCray PB Jr. (2005) Expression and activity of beta-defensins and LL-37 in the developing human lung. J Immunol 174 : 1608 1615.
29. Terai K, Sano Y, Kawasaki S, Endo K, Adachi W, Hiratsuka T, Ihiboshi H, Nakazato M Kinoshita S (2004) Effects of dexamethasone and cyclosporin a on human beta-defensin in corneal epithelial cells. Exp Eye Res 79 : 175 180.
30. Territo MC, Ganz T, Selsted ME Lehrer R (1989) Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 84 : 2017 2020.
31. Theodosiou A Ashworth A (2002) MAP kinase phosphatases. Genome Biol 3, REVIEWS3009.
32. Toh ML, Yang Y, Leech M, Santos L Morand EF (2004) Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids. Arthritis Rheum 50 : 3118 3128.
33. Tomita T, Nagase T, Ohga E, Yamaguchi Y, Yoshizumi M Ouchi Y (2002) Molecular mechanisms underlying human beta-defensin-2 gene expression in a human airway cell line (LC2/ad). Respirology 7 : 305 310.
34. Tsutsumi-Ishii Y Nagaoka I (2002) NF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation. J Leukoc Biol 71 : 154 162.
35. Tsutsumi-Ishii Y Nagaoka I (2003) Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 170 : 4226 4236.
36. Wehkamp J, Harder J, Wehkamp K et al 2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72 : 5750 5758.
37. Witthoft T, Pilz CS, Fellermann K, Nitschke M, Stange EF Ludwig D (2005) Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2). Dig Dis Sci 50 : 1252 1259.
38. Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H Ouchi Y (2002) Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol 169 : 2516 2523.
39. Yang D, Chertov O, Bykovskaia SN et al 1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 : 525 528.
40. Zhao C, Wang I Lehrer RI (1996) Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 396 : 319 322.